InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,842.47
(
0.47%
)
US TECH 100
19,625.60
(
-0.04%
)
Dow Jones
43,077.70
(
0.79%
)
Brent Oil
74.27
(
-0.27%
)
Bitcoin
67,614.97
(
0.91%
)
Post# of 1189
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

rainbow898

Send PM Follow Ignore
Followers 0
Posts 5633
Boards Moderated 0
Alias Born 05/05/2005

rainbow898

Re: Deuces post# 551

Wednesday, 01/20/2016 5:54:44 AM

Wednesday, January 20, 2016 5:54:44 AM

Post# of 1189
Yeap, good partnership for AVDX.

Concurrent with this announcement, Amarantus Diagnostics has entered into an agreement with a Maryland-based CLIA laboratory to house its assays in preparation for CLIA-enabling validation studies. Upon closing of the merger transaction, Avant Diagnostics will take over this agreement and be positioned to complete the development of OvaDx in that CLIA-certified facility.



http://finance.yahoo.com/news/amarantus-enters-letter-intent-merge-140000225.html


Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up